National Cancer Institute · PDF fileHighlights of NCI’s Recent Progress in Pancreatic...

79
i Pancreatic Cancer: A Summary of NCI’s Portfolio and Highlights of Recent Research Progress September 2010 U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute

Transcript of National Cancer Institute · PDF fileHighlights of NCI’s Recent Progress in Pancreatic...

  • i

    Pancreatic Cancer: A Summary of NCIs Portfolio

    and Highlights of Recent Research Progress

    September 2010

    U.S. Department of Health and Human Services

    National Institutes of Health

    N

    atio

    nal C

    ance

    r Ins

    titut

    e

  • Pancreatic Cancer: A Summary of NCIs Portfolio & Highlights of Recent Research Progress

    Table of Contents

    Highlights of NCIs Recent Progress in Pancreatic Cancer....................................... iv The Pancreatic Cancer Burden......................................................................................1

    Pancreatic Cancer Incidence Rates......................................................................................................... 1 Pancreatic Cancer Mortality Rates ......................................................................................................... 3

    NCI Planning for Pancreatic Cancer Research ............................................................4 Pancreatic Cancer Progress Review Group ..................................................................................... 4 Clinical Trials Planning Meeting on Pancreas Cancer Treatment ................................................... 5

    NCIs Investment in Pancreatic Cancer Research .......................................................7 Health of the Field and Overarching Issues............................................................................ 7

    NCI Funding for Pancreatic Cancer Research................................................................................. 7 Pancreatic-Cancer-Focused Research Projects and Trials............................................................... 8 Research Projects ............................................................................................................................ 8 Clinical Trials ................................................................................................................................ 10 Specialized Programs of Research Excellence .............................................................................. 11 Increased Capacity Building in Pancreatic Cancer Research ........................................................ 11 Growth in Number of Investigators............................................................................................... 11 Training ......................................................................................................................................... 14 Growth in Number of Publications................................................................................................ 15

    Tumor Biology.......................................................................................................................... 16 Research Projects .......................................................................................................................... 16 Initiatives ....................................................................................................................................... 16 Research Highlights ...................................................................................................................... 17

    Risk, Prevention, Screening, and Diagnosis......................................................................... 18 Research Projects .......................................................................................................................... 18 Clinical Trials ................................................................................................................................ 18 Initiatives ....................................................................................................................................... 18 Research Highlights ...................................................................................................................... 20

    Therapy ..................................................................................................................................... 21 Research Projects .......................................................................................................................... 21 Clinical Trials ................................................................................................................................ 22 Initiatives ....................................................................................................................................... 23 Research Highlights ...................................................................................................................... 23

    Health Services Research....................................................................................................... 24 Research Projects .......................................................................................................................... 24 Initiatives ....................................................................................................................................... 24 Research Highlights ...................................................................................................................... 25

    Scientific Toolkit ...................................................................................................................... 25 Research Projects .......................................................................................................................... 25 Initiatives ....................................................................................................................................... 26 Research Highlights ...................................................................................................................... 26

    Clinical Trials Planning Meeting on Pancreas Cancer Treatment ...................................... 26 American Recovery and Reinvestment Act of 2009............................................................. 27

    Funding Mechanisms .................................................................................................................... 27 PRG Priority Areas........................................................................................................................ 28 Clinical Trials Planning Meeting Emphasis Areas........................................................................ 28

    Conclusion.....................................................................................................................30 Appendix: NCI FY2009 Projects Coded to Pancreatic Cancer Progress Review

    Group Recommendations ............................................................................................31

    i

  • Pancreatic Cancer: A Summary of NCIs Portfolio & Highlights of Recent Research Progress

    List of Figures

    Figure 1. Estimated New Cases and Deaths for Pancreatic Cancer by Year, 2004-2010 ................1

    Figure 2. Incidence Rate Trends for Pancreatic Cancer by Racial/Ethnic Group, 1982-2007.........2

    Figure 3. Male-Female Incidence Rate Trends for Pancreatic Cancer, 1982-2007 .........................2

    Figure 4. Mortality Rate Trends for Pancreatic Cancer, 1982-2007 ................................................3

    Figure 5. Male-Female Mortality Rate Trends for Pancreatic Cancer, 1982-2007..........................3

    Figure 6. Trends in NCI Funding for Pancreatic Cancer, FY2000-FY2009 ....................................7

    Figure 7. Dollar Estimates for Extramural Research in Pancreatic Cancer by Scientific Area,

    FY2007-FY2009..........................................................................................................9

    Figure 8. Total Number of NCI-Sponsored Research Projects Relevant to Pancreatic Cancer, FY2000-FY2009..........................................................................................................9

    Figure 9. Pancreatic Cancer Research by PRG Category, FY2000-FY2009 .................................10

    Figure 10. NCI-Sponsored Clinical Trials Related to Pancreatic Cancer by Phase, July FY2010 ..............................................................................................................10

    Figure 11. NCI-Sponsored Clinical Trials Related to Pancreatic Cancer by Focus, July FY2010 ..............................................................................................................11

    Figure 12. Number of Investigators With at Least One R01 Grant Relevant to Pancreatic Cancer, FY2000-FY2009 ..........................................................................................13

    Figure 13. Extramural Training Awards for Pancreatic Cancer Research, FY2005-FY2009........14

    Figure 14. Percent by Mechanism of Extramural Training and Career Development Awards, FY2009 ......................................................................................................................15

    Figure 15. Estimated Number of Scientific Articles on Pancreatic Cancer Research Acknowledging NCI Support, 2000-2009.................................................................16

    Figure 16. Pancreatic Cancer Projects Related to Tumor Biology, FY2000 and FY2009.............17

    Figure 17. Pancreatic Cancer Projects Related to Risk, Prevention, Screening, and Diagnosis, FY2000 and FY2009 .................................................................................................19

    Figure 18. Pancreatic Cancer Projects Related to Therapy, FY2000 and FY2009 ........................22

    Figure 19. Pancreatic Cancer Projects Related to Health Services Research, FY2000 and FY2009 ................................................